Surgery Partners Inc
NASDAQ:SGRY

Watchlist Manager
Surgery Partners Inc Logo
Surgery Partners Inc
NASDAQ:SGRY
Watchlist
Price: 21.23 USD 2.86% Market Closed
Market Cap: 2.7B USD

Surgery Partners Inc
Investor Relations

Surgery Partners Inc., a prominent player in the healthcare industry, orchestrates a robust network of surgical facilities across the United States. The company's business model is centered around operating and acquiring a variety of healthcare services, primarily focusing on short-stay surgeries through its ambulatory surgery centers, surgical hospitals, and ancillary services. Founded in 2004, Surgery Partners has grown its footprint by honing in on cost-effective, high-quality outpatient surgery, offering a compelling alternative to traditional hospital settings. This approach not only reduces healthcare costs for patients and insurers but also provides an efficient model for physicians looking to practice in specialized surgical environments.

Revenue generation for Surgery Partners is multifaceted, deriving primarily from patient service fees and strategic partnerships with healthcare providers and insurers. By maintaining a diversified portfolio that includes musculoskeletal surgeries, cardiac procedures, and other specialist operations, the company captures a broad spectrum of medical needs. Additionally, it benefits from ancillary services such as anesthesia and pathology, which are critical components of the surgical process. This integrated service offering allows Surgery Partners to maximize revenue streams while maintaining a strong presence in the outpatient surgery market. The company’s collaborative approach, working closely with physicians and leveraging strategic acquisitions, fortifies its position as a leader in the evolution toward more efficient, patient-centric healthcare delivery.

Show more
Loading

Earnings Calls

2024 Q3
Nov 12, 2024
Show Transcript
Previous
Next
Surgery Partners Reports Robust Growth Amid Challenges
2024 Q3
Nov 12, 2024

In the third quarter, Surgery Partners reported a net revenue of $770 million, up over 14% year-on-year. Adjusted EBITDA grew 22% to $128.6 million, marking a margin increase to 16.7%. Surgical case volume rose 3.7%, with total joint replacements soaring by 53%. Despite disruptions from two hurricanes, all facilities are operational again. The company is optimistic about future growth, targeting full-year revenues exceeding $3.075 billion and adjusted EBITDA of $508 million, reflecting at least 13% and 16% growth, respectively. Ongoing strategic acquisitions and a strong recruitment drive are key to sustaining this momentum.

Show Full Analysis

Management

Mr. Wayne Scott DeVeydt
Executive Chairman
No Bio Available
Mr. J. Eric Evans
CEO & Director
No Bio Available
Mr. David T. Doherty CPA
Executive VP & CFO
No Bio Available
Ms. Jennifer B. Baldock J.D.
Executive VP and Chief Administrative & Development Officer
No Bio Available
Ms. Marissa A. Brittenham
Executive VP & Chief Strategy Officer
No Bio Available
Ms. Kristi Jensen
Senior Vice President of Operations - Central Region
No Bio Available
Mr. Neil C. Zieselman
Senior Vice President of Corporate Finance & Controller
No Bio Available
Mr. Varun Gadhok
Senior VP & Chief Information Officer
No Bio Available
Ms. Roxanne Womack
Senior VP & Chief Compliance Officer
No Bio Available
Mr. Spencer Clark
General Counsel & Senior VP
No Bio Available

Contacts

Address
TENNESSEE
Brentwood
310 Seven Springs Way Ste 500
Contacts